0000000016 00000 n Promote your business to the leaders in Indiana's health care industry. OTR~PONB*IHC#pUH5Wc"wb-gPqtr:yPxu`& L k! This guide is to aid wound assessment and management, and should Wound Care Formulary | NI Formulary - HSCNI <]/Prev 376811/XRefStm 1838>> 0000002265 00000 n The aim of the Northern Ireland Wound Care Formulary is to provide practitioners with guidance on the wound management products that are recommended for use in Northern Ireland. endobj share this article with the institution you work with, Request for Non-Formulary Wound Care Product. Important: Only the version of this document available from . 4 0 obj 4 0 obj PDF Wound Care Formulary 1150 0 obj <>stream 5479 28 5: Infections (Antimicrobial Guidelines) norfolk & Waveney CCG wound care Formulary companion and guide For a personalized demo, contact us. This article provides steps and tips on how to set up a formulary for your institution and how to optimize an existing formulary. Version: 3.2 Ref: 936 Owner: Kerry Carmichael Page 4 of 28 Issued: 8.12.2022 Title: Wound Management Formulary (Adults) and Guidance Document 1. PDF Wound Care Formulary Wirral Community NHS Foundation Trust 2020 Hydrofilm) may be appropriate. Scottish Wound Assessment and Action Guide (SWAAG) NICE, London National Institute for Health and Care Excellence (2020) Venous eczema and lipodermatosclerosis. Find out if your facility or hospital has a binding purchasing contract with specific manufacturers or distributors. If your browser does not render page correctly, please read the page content below, We use cookies. | Wound Care ICD-10 Coding, Coding and Reimbursement Guidelines for Wound Care | 2020 ICD-10 Codes for Wound Care: Updates and Interactive Tool, Reducing Errors and Liability in Wound Care | ICD-10 Codes: 2020 Updates and Interactive Tool for Wound Care Professionals, Defining Your Wound Care Program's Scope of Service | Transfer of Post-operative Care to the Wound Clinic, How to Perform Conservative Sharp Wound Debridement: Protocols, Troubleshooting, Reimbursement | Digital Formulary, Post-operative Care by Wound Services: Getting Reimbursed | Is Adjunct HBOT Effective for Female Infertility? 0000099228 00000 n Wound Care Formulary Guidelines - August 2020 FINAL Prescribing in palliative care. PDF NHS Greater Glasgow and Clyde Wound Formulary - GGC Medicines Many institutions have binding contracts to obtain tiered discounts on the amount of products purchased, which incentivizes the institution to purchase solely from a specific supplier. This is important so that you can proceed to the next step below Educate clinicians. The wound care formulary companion and guide provides clinical staff with comprehensive information on wound healing and wound care products. 1113 0 obj <> endobj endobj 0000010736 00000 n <> may result inmore than 38% savings in inventory costs and increased staff efficiency. - November, 2021, When and How to Perform Wound Cultures | Engaging Your Patients | Hyperbaric Category A Credits - September, 2021, How to Screen, Assess and Manage Nutrition in Patients with Chronic Wounds - June, 2021, How Safe Is Your Hyperbaric Program? Volume 13 - 2022; Volume 12 - 2021; Volume 14-2023; Volume 11 - 2020; Volume 10 - 2019; Volume 9 - 2018; Volume 8 - 2017; Volume 7 - 2016; Volume 6 - 2015; Volume 5 - 2014; Volume 4 - 2013; Volume 3 . Back to Gloucestershire Hospitals NHS Foundation Trust website, https://ccglive.glos.nhs.uk/intranet/index.php/ccg-strategy/medicines-management/formularies/glos-dressing-formulary, Copyright Gloucestershire Hospitals 2023. x=r7?[ \RTRm})JbE" `h`8DS h zG?x|_,oWW~{_Wg7bn.vzY5s'_SwV22zXxb&S,.Fgg7+FKAgLcBRRD7 IY4wtg D`X"Q*e\wn]9Pd m~l;gg~O~e_cea{hF]wgA ;xy endobj 0000001838 00000 n MMT & supports the implementation of formulary choices contained in the Somerset Wound Formulary. Wound Care Management Formulary Amendment History VERSION DATE AMENDMENT HISTORY 4.0 December 2014 Previous version 5.0 September 2015 Comments - Additional products added and . be used in line with local policy/guidelines. not Wound Care Non-Formulary dressing request form For Local Decisions on wound formulary please follow this link https://www.enhertsccg.nhs.uk/dressings Last modified: 07 Feb 2020 After your team agrees with the products in the formulary, run it by the Hospital Value Analysis Team or Improvement Team (or similar) for feedback and approvals. The formulary provides for a wide range of wound types, descriptions and advice on the most appropriate product (s) to use. Clinical Decision Support Tool. Wales NHS, UK Wound Dressing Formulary [Online]. Please refer to main wound care formulary document for further information and guidance. Wound Care | NHS East and North Hertfordshire Clinical - enhertsccg What features are important for each product type? In that way, you can ensure that when you refer a patient, your wound care orders will be carried out at the receiving facility. 1.1 Dyspepsia and gastro-oesophageal reflux disease (GORD), 1.1.2 Compound alginates and proprietary indigestion preparations, 1.2 Antispasmodics and other drugs altering gut motility, 1.3 Antisecretory drugs and mucosal protectants, 1.5.1.1 Acute Exacerbation of ulcerative colitis, 1.5.1.2 Maintenance of remission of ulcerative colitis, 1.5.2 Corticosteroids inflammatory bowel disease, 1.5.3 Steroid-sparing treatment for inflammatory bowel disease, 1.7 Local preparations for anal and rectal disorders, 1.7.1 Soothing haemorrhoidal preparations, 1.7.2 Compound haemorrhoidal preparations with corticosteroids, 1.9 Drugs affecting intestinal secretions, 2.2.3 Potassium-sparing diuretics and aldosterone antagonists, 2.2.4 Potassium-sparing diuretics with other diuretics, 2.5.2 Centrally acting antihypertensive drugs, 2.5.5 Drugs affecting the renin-angiotensin system, 2.5.5.1 Angiotensin-converting enzyme inhibitors, 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs), 2.6 Nitrates, calcium-channel blockers and other antianginal drugs, 2.6.4 Peripheral vasodilators and related drugs, 2.8.2.2 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent, 2.8.2.3 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only, 2.8.2.5 Prevention of Atherothrombotic events, 2.10 Stable angina, acute coronary syndromes and fibrinolysis, 2.11 Antifibrinolytic drugs and haemostatics, 3.1.4 Compound bronchodilator preparations, 3.1.5 Peak flow meters, inhaler devices and nebulisers, 3.2.1 Single agent inhalers [asthma only], 3.2.2 Compound ICS/LABA preparations [asthma], 3.2.3 Compound ICS/LABA preparations COPD, 3.3 Leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors, 3.3.3 Phosphodiesterase type-4 inhibitors, 3.4 Antihistamines, hyposensitisation and allergic emergencies, 3.4.2 Allergen immunotherapy (desensitisation), 4.2 Drugs used in psychoses and related disorders, 4.2.1.1 Management of agitation and aggression, 4.2.3.1 Treatment of the acute phase of mania, 4.2.3.2 Maintenance treatment of bipolar disorder with mood stabilisers, 4.3.1 Mild, moderate and severe depression, 4.3.2 Antidepressants for the treatment of anxiety disorders*, 4.3.2.1 Generalised anxiety disorder (GAD), social anxiety disorder, 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder, 4.4.2 Attention deficit hyperactive disorder (ADHD) in adults, 4.5 Drugs used in the treatment of obesity, 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract, 4.6.1 Drugs for the short-term treatment of nausea and vomiting, 4.7.4.1 Treatment of acute migraine attack, 4.7.4.3 Drug treatment of cluster headache, 4.9 Drugs used in parkinsonism and related disorders, 4.9.1 Dopaminergic drugs used in parkinsonism, 4.9.1.3 Monoamine-oxidase-B (MAOB) inhibitors, 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors), 4.9.2 Antimuscarinic drugs used in parkinsonism, 4.9.4 Management of dementia in Parkinsons disease, 4.10 Medications used in substance use disorders, 4.10.3 Benzodiazepine and Z drug withdrawal, 4.10.4.3 Interventions for the reduction of alcohol consumption, 4.11.1 Management of Behavioural and Psychological Symptoms of Dementia (BPSD), 6.1.2.3 Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), 6.1.2.5 Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 6.1.6 Diagnostic and monitoring agents for diabetes mellitus, Summary of oral drug treatments for type 2 diabetes, 6.2 Thyroid and antithyroid drugs and parathyroid disease, 6.4.1.1 Hormone replacement therapy (HRT) for menopausal symptoms, 6.4.1.1a Women who have not had a hysterectomy, 6.4.1.1b Women who have had a hysterectomy or who have a Mirena Intra Uterine System (ISU) in situ, 6.5 Pituitary hormones and anti-oestrogens, 6.5.2 Posterior pituitary hormones and antagonists, 6.5.2.2 Antidiuretic hormone antagonists, 6.6.1 Drugs for the treatment and management of osteoporosis, 6.6.1.3 Other drug therapies used in osteoporosis, 7.0 Contraception, Gynaecology and Urinary Tract Disorders, 7.1.3 Endometriosis (previously diagnosed by laparoscopy), 7.2 Treatment of vaginal and vulval conditions, 7.2.1 Preparations for vaginal and vulval changes, Review copy of Review copy of 7.2.2 Vaginal and vulval infections, 7.3.1 Combined hormonal oral contraceptives, 7.3.2.1 Oral progestogen-only contraceptives, 7.3.2.2 Parenteral progestogen-only contraceptives, 7.3.2.3. |X -Q4zLh0Z8j!%F6U0Ta E1C /eRS",ZxfQ(4.F2Ei Yyjs [6(! Nurse Formulary Order Form: . The Wound Care Guidelines have been written by the Tissue Viability Team and is based on a wide range of clinical evidence and peer reviews. To replicate your formulary within WoundReference and confirm optimal product choice, follow steps described in Setting up your formulary. %PDF-1.7 Click on the following link to access the Gloucestershire Wound Management Formulary. 0 2 0 obj 1 0 obj In the Wound Formulary we have provided an Exception Reporting form (available electronically) for use when non-formulary products are used. Wound formulary to be monitored by the Therapeutics subgroup of the Area Drugs and Therapeutics Committee. The wound care formulary has been developed to reduce unwanted variation and cost. 3: Respiratory System. Carry on browsing if youre happy with this or read more about our cookie policy and privacy policy. 0000008635 00000 n Are your patients only seen at your facility or do they get referred to other settings, such as skilled nursing facilities, home health, community health clinics, etc? These leaders are the ones who will create engagement, change practice and lead the team when creating the formulary and directly improve patient care by driving clinical practice decision making. The wound assessment must be completed by a registered nurse or other healthcare professional. PDF Quick Reference Dressings Guide August 2020 update - Somerset CCG CID: 902 Published: September 2013 Last Review: September 2020 Next Review: September 2023 The information relating to each product isPaper copies of this document should be kept to a minimum and checks made with the electronic version to ensure that the printed version is the most recent. Includes approved dressings and appliances. Updated results showed a 36% decrease in the number of products utilized by the facility (67 to 43 across 22 types), 38.73% decrease in the monthly average . This formulary will assist clinical staff in a variety of settings including GP Practices, nursing homes . | Wound Care ICD-10 Coding - Oct 25, 2019, Coding and Reimbursement Guidelines for Wound Care | 2020 ICD-10 Codes for Wound Care: Updates and Interactive Tool - Oct 18, 2019, Reducing Errors and Liability in Wound Care | ICD-10 Codes: 2020 Updates and Interactive Tool for Wound Care Professionals - Oct 11, 2019, Defining Your Wound Care Program's Scope of Service | Transfer of Post-operative Care to the Wound Clinic - Oct 4, 2019, How to Perform Conservative Sharp Wound Debridement: Protocols, Troubleshooting, Reimbursement | Digital Formulary - Sept 18, 2019, Post-operative Care by Wound Services: Getting Reimbursed | Is Adjunct HBOT Effective for Female Infertility? <>/Metadata 6222 0 R/ViewerPreferences 6223 0 R>> We have more than 100 providers caring for over 3,000 patients in Long Term Care, Acute Care, Skilled Nursing facilities, and in-home health. Version 1 produced by JWFG 2018, Reviewed by JWFWG October 2020, Version 2 Approved at DMAG Nov 2020, Next review Nov 2022 Melolin/Melolite Biatain Silicone Lite (Melolite only available to secondary care via UrgoTul Absorb +/ Zetuvit Plus 3`gv4@%]{/X;`?0L3SN ]E^` [ %PDF-1.7 <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 20 0 R 21 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> <>/Metadata 2891 0 R/ViewerPreferences 2892 0 R>> When and How to Perform Wound Cultures | Engaging Your Patients | Hyperbaric Category A Credits, How to Screen, Assess and Manage Nutrition in Patients with Chronic Wounds, How Safe Is Your Hyperbaric Program? Experienced Wound Care Physicians/Mid-Levels , PT/Physician Product Available Sizes SKU PECOS Pack Size . Wound Care Today - Article: Differentiating between cellulitis Z#hHp0f"z0)Nbo#93VgGXpK0"0 -w'JZ^s[^g7[YO8a0(%JqA9H$l VsZn(=I}|.w' ]iA.IH6'HYW2V%Cmg/K6MJAn96+Q_YD^XFL[CmeqZx{xZYVN6sK))B`2P$O J&?2mQ0!k_a~0Kj!Ru\8n +X66``9?+r *Q"]L+]%NF~:.SVGs_jOuu\.k Implementation 2019 2021 - Aurora Health Care, Welcome to the Long-Term Care Best Practice Spotlight Organization - Information Webinar - RNAO, Teenage Education Payment Guidelines - PSP Learning Hub.